Genes and Environment as Predisposing Factors in Autoimmunity: Acceleration of Spontaneous Thyroiditis by Dietary Iodide in NOD.H2h4 Mice

International Reviews of Immunology

Volumn 34, Issue 6, 2015, Pages 542-556

  Kolypetri, Panayota ^a   King, Justin ^a   Larijani, Mani ^a   Carayanniotis, George ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

iodine; NOD.H2hh4 mice; thyroglobulin; thyroiditis

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 4; IODIDE; T LYMPHOCYTE ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1; AUTOANTIBODY; CYTOKINE; THYROGLOBULIN;

AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL SPECIFICITY; DISEASE PREDISPOSITION; ENVIRONMENT; GENE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SPONTANEOUS AUTOIMMUNE THYROIDITIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYROID FUNCTION; ADVERSE EFFECTS; ANIMAL; DIETARY SUPPLEMENT; DISEASE MODEL; GENE EXPRESSION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY; THYROIDITIS, AUTOIMMUNE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CYTOKINES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ENVIRONMENT; GENE EXPRESSION; GENE-ENVIRONMENT INTERACTION; HUMANS; IODIDES; MICE; MICE, INBRED NOD; T-LYMPHOCYTE SUBSETS; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE;

EID: 84947025325     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2015.1065828     Document Type: Review

References (100)

1. Anderson MS, Bluestone JA. The NOD mouse: A model of immune dysregulation. Annu Rev Immunol 2005;23:447-485.
2. Bernard NF, Ertug F,MargoleseH. High incidence of thyroiditis and anti-thyroid autoantibodies in NODmice. Diabetes 1992;41(1):40-46.
3. Asamoto H, OishiM, Akazawa Y, et al. Tochino Y. Histologiacal and immunological changes in the thymus and other organs in NOD mice. In: Tarui S, Tochino Y, Nonaka K, editors. Insulitis and type 1 diabetes-Lessons fromthe NODmouse. Tokyo: Academic Press; 1986. p. 61.
4. Castano L, Eisenbarth GS. Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990;8:647-679.
5. Damotte D, Colomb E, Cailleau C, et al. Analysis of susceptibility of NOD mice to spontaneous and experimentally induced thyroiditis. Eur J Immunol 1997;27(11):2854-2862.
6. Many MC,Maniratunga S, Varis I, et al. Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol 1995;147(2):311-320.
7. Vecchiatti SM, GuzzoML, Caldini EG, et al. Iodine increases and predicts incidence of thyroiditis in NODmice: Histopathological and ultrastructural study. Exp TherMed 2013;5(2):603-607.
8. Podolin PL, Pressey A, DeLarato NH, et al. I-E +nonobese diabetic mice develop insulitis and diabetes. J ExpMed 1993;178(3):793-803.
9. Weatherall D, Sarvetnick N, Shizuru JA. Genetic control of diabetes mellitus. Diabetologia 1992;35(Suppl 2):S1-7.
10. Burek CL, Talor MV. Environmental triggers of autoimmune thyroiditis. J Autoimmun 2009;33(3-4):183-189.
11. Alam C, Bittoun E, Bhagwat D, et al. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD)mice. Diabetologia 2011;54(6):1398-1406.
12. Cihakova D, TalorMV, Barin JG, et al. Sex differences in amurinemodel of Sjogren's syndrome. Ann N Y Acad Sci 2009;1173:378-383.
13. Karnell JL,Mahmoud TI, Herbst R, et al. Discerning the kinetics of autoimmune manifestations in amodel of Sjogren's syndrome. Mol Immunol 2014;62(2):277-282.
14. Tomazic V, Rose NR, Shreffler DC. Autoimmunemurine thyroiditis. IV. Localization of genetic control of the immune response. J Immunol 1974;112(3):965-969.
15. Kong YM, David CS, Lomo LC, et al. Role ofmouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics 1997;46(4):312-317.
16. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in theNODmouse. Annu Rev Immunol 1995;13:179-200.
17. BoulardO,Damotte D,DeruytterN, et al. An interval tightly linked to but distinct fromthe H2 complex controls both overt diabetes (Idd16) and chronic experimental autoimmune thyroiditis (Ceat1) in nonobese diabetic mice. Diabetes 2002;51(7):2141-2147.
18. Rasooly L, Burek CL, Rose NR. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol 1996;81(3):287-292.
19. Braley-Mullen H, Sharp GC,Medling B, et al. Spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J Autoimmun 1999;12(3):157-165.
20. Kolypetri P, Noel NA, Carayanniotis KA, et al. Iodine content of thyroglobulin in Nod. H2h4 mice developing iodine-accelerated autoimmune thyroiditis. Hormones (Athens) 2010;9(2):151-160.
21. Teng X, Shan Z, Teng W, et al. Experimental study on the effects of chronic iodine excess on thyroid function, structure, and autoimmunity in autoimmune-proneNOD. H-2h4mice. Clin ExpMed 2009;9(1):51-59.
22. Li HS, Carayanniotis G. Induction of goitrous hypothyroidism by dietary iodide in SJL mice. Endocrinology 2007;148(6):2747-2752.
23. Hutchings PR, Verma S, Phillips JM, et al. Both CD4(+) T cells and CD8(+) T cells are required for iodine accelerated thyroiditis in NODmice. Cell Immunol 1999;192(2):113-121.
24. Tani J,Mori K,Hoshikawa S, et al. Prevention of lymphocytic thyroiditis in iodide-treated non-obese diabetic mice lacking interferon regulatory factor-1. Eur J Endocrinol 2002;147(6):809-814.
25. Mori K, Nakagawa Y, Hoshikawa S, et al. Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in nonobese diabeticmice? Clin Immunol 2009;130(3):375-377.
26. Flynn JC, Meroueh C, Snower DP, et al. Depletion of CD4+CD25 +regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB10301) transgenic class II-knock-out non-obese diabetic mice. Clin Exp Immunol 2007;147(3):547-554.
27. Iodine. In: Vitamin and Mineral Requirements in Human Nutrition, 2nd Edition. Report of a Joint FAO/WHO Expert Consultation, 21-30 September, 1998, Bangkok,Thailand. Publisher:World Health Organization and Food and Agricultural Organization of the United Nations, 2004. p. 303-317.
28. Burgi H. Iodine excess. Best Pract Res Clin EndocrinolMetab 2010;24(1):107-115.
29. Luo Y, Kawashima A, Ishido Y, et al. Iodine excess as an environmental risk factor for autoimmune thyroid disease. Int JMol Sci 2014 ;15(7):12895-12912.
30. Bonita RE, Rose NR, Rasooly L, et al. Kinetics of mononuclear cell infiltration and cytokine expression in iodine-induced thyroiditis in the NOD-H2h4 mouse. ExpMol Pathol 2003;74(1):1-12.
31. Yu S,Medling B, Yagita H, et al. Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD. H-2h4 mice. J Autoimmun 2001;16(1):37-46.
32. Nagayama Y, Horie I, Saitoh O, et al. CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NODH2h4 mice. J Autoimmun 2007;29(2-3):195-202.
33. Yang X, Gao T, Shi R, et al. Effect of iodine excess on Th1,Th2, Th17, and Treg cell subpopulations in the thyroid of NOD. H-2h4 mice. Biol Trace Elem Res 2014;159(1-3):288-296.
34. Oppenheim Y, Kim G, Ban Y, et al. The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4mouse. Clin Dev Immunol 2003;10(2-4):161-165.
35. Nagayama Y, Kaminoda K,Mizutori Y, Exacerbation of autoimmune thyroiditis by a single lowdose of whole-body irradiation in non-obese diabetic-H2h4mice. Int J Radiat Biol 2008;84(9):761-769.
36. Nagayama Y, IchikawaT, Saitoh O, et al. Induction of late-onset spontaneous autoimmune thyroiditis by a single low-dose irradiation in thyroiditis-prone non-obese diabetic-H2h4mice. J Radiat Res 2009;50(6):573-577.
37. King C, Ilic A, Koelsch K, et al. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004;117(2):265-277.
38. Verma S, Hutchings P, Guo J, et al. Role of MHC class I expression and CD8(+) T cells in the evolution of iodine-induced thyroiditis in NOD-H2(h4) and NOD mice. Eur J Immunol 2000;30(4):1191-1202.
39. Nagayama Y, Nakahara M, Shimamura M, et al. Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves' hyperthyroidism, in mice. Clin Exp Immunol 2012;168(3):268-273.
40. Yu S, Maiti PK, Dyson M, et al. B cell-deficient NOD. H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J Exp Med 2006;203(2):349-358.
41. Xue H, Wang W, Shan Z, et al. Dynamic changes of CD4+CD25 +regulatory T cells in NOD. H-2h4 mice with iodine-induced autoimmune thyroiditis. Biol Trace Elem Res 2011;143(1):292-301.
42. Shi L, BiM, Yang R, et al. Defective expression of regulatory B cells in iodine-induced autoimmune thyroiditis in non-obese diabetic H-2(h4)mice. J Endocrinol Invest 2014;37(1):43-50.
43. Xue H, Wang W, Li Y, et al. Selenium upregulates CD4(+)CD25(+) regulatory T cells in iodineinduced autoimmune thyroiditis model of NOD. H-2(h4) mice. Endocr J 2010;57(7):595-601.
44. Ellis JS, Hong SH, Zaghouani H, et al. Reduced effectiveness of CD4+Foxp3+ regulatory T cells in CD28-deficientNOD. H-2h4mice leads to increased severity of spontaneous autoimmune thyroiditis. J Immunol 2013;191(10):4940-4949.
45. Bour-Jordan H,Thompson HL, Giampaolo JR, et al. Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background. J Autoimmun 2013;45:58-67.
46. Bour-Jordan H, Bluestone JA. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 2009;229(1):41-66.
47. Horie I, Abiru N, Nagayama Y, et al. T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice. Endocrinology 2009;150(11):5135-5142.
48. Horie I, Abiru N, Sakamoto H, et al. Induction of autoimmune thyroiditis by depletion of CD4+CD25+ regulatory T cells in thyroiditis-resistant IL-17, but not interferon-gamma receptor, knockout nonobese diabetic-H2h4mice. Endocrinology 2011;152(11):4448-4454.
49. Bai X, Sun J,Wang W, et al. Increased differentiation ofTh22cells inHashimoto's thyroiditis. Endocr J 2014;61(12):1181-1190.
50. Burek CL, Sharma RB, Rose NR. NKT cell regulation of autoimmune thyroiditis. Autoimmunity 2003;36(6-7):405-408.
51. Sharma RB, Fan X, Caturegli P, et al. Invariant NKT Cell Lines Derived from the NOD. H2 Mouse Enhance AutoimmuneThyroiditis. JThyroid Res 2011;2011:895923.
52. Barin JG, Talor MV, Sharma RB, et al. Iodination of murine thyroglobulin enhances autoimmune reactivity in the NOD. H2 mouse. Clin Exp Immunol 2005;142(2):251-259.
53. Kaufman DL,Tisch R, Sarvetnick N, et al. Report fromthe 1st InternationalNODMouseT-CellWorkshop and the follow-upmini-workshop. Diabetes 2001;50(11):2459-2463.
54. Sundick RS, Herdegen DM, Brown TR, et al. The incorporation of dietary iodine into thyroglobulin increases its immunogenicity. Endocrinology 1987;120(5):2078-2084.
55. Champion BR, Rayner DC, Byfield PG, et al. Critical role of iodination for T cell recognition of thyroglobulin in experimentalmurine thyroid autoimmunity. J Immunol 1987;139(11):3665-3670.
56. Li HS,Carayanniotis G. Iodination of tyrosyls in thyroglobulin generates neoantigenic determinants that cause thyroiditis. J Immunol 2006;176(7):4479-4483.
57. Li HS, Jiang HY, Carayanniotis G. Modifying effects of iodine on the immunogenicity of thyroglobulin peptides. J Autoimmun 2007;28(4):171-176.
58. Jiang HY, Li HS, Carayanniotis K, et al. Variable influences of iodine on the T-cell recognition of a single thyroglobulin epitope. Immunology 2007;121(3):370-376.
59. Hill JA, Southwood S, Sette A, et al. Cutting edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB10401MHC class IImolecule. J Immunol 2003;171(2):538-541.
60. Champion BR, Page KR, Parish N, et al. Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells. J ExpMed 1991;174(2):363-370.
61. Hutchings PR, Cooke A, Dawe K, et al. A thyroxine-containing peptide can induce murine experimental autoimmune thyroiditis. J ExpMed 1992;175(3):869-872.
62. Kolypetri P, Carayanniotis K, Rahman S, et al. The thyroxine-containing thyroglobulin peptide (aa 2549-2560) is a target epitope in iodide-accelerated spontaneous autoimmune thyroiditis. J Immunol 2014;193(1):96-101.
63. Carayanniotis G. The cryptic self in thyroid autoimmunity: The paradigm of thyroglobulin. Autoimmunity 2003;36(6-7):423-428.
64. Carayanniotis G. Recognition of thyroglobulin by T cells: The role of iodine. Thyroid 2007;17(10):963-973.
65. Carayanniotis G. Molecular parameters linking thyroglobulin iodination with autoimmune thyroiditis. Hormones (Athens) 2011;10(1):27-35.
66. Calderon B, Suri A, Miller MJ, et al. Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proc Natl Acad Sci USA 2008;105(16):6121-6126.
67. Mohan JF, Unanue ER. Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat Rev Immunol 2012;12(10):721-728.
68. Calderon B, Unanue ER. Antigen presentation events in autoimmune diabetes. CurrOpin Immunol 2012;24(1):119-128.
69. Braley-MullenH, Yu S. NOD. H-2h4Mice: An Important and underutilized animal model of autoimmune thyroiditis and Sjogren's syndrome. Adv Immunol 2015;126:1-43.
70. Braley-Mullen H, Yu S. Early requirement for B cells for development of spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J Immunol 2000;165(12):7262-7269.
71. Yu S, Ellis JS, Dunn R, et al. Transient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adults. Int Immunol 2012;24(4):233-242.
72. Yu S, Dunn R, Kehry MR, et al. B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD. H-2h4mice. J Immunol 2008;180(11):7706-7713.
73. Hong SH, Braley-Mullen H. Follicular B cells in thyroids of mice with spontaneous autoimmune thyroiditis contribute to disease pathogenesis and are targets of anti-CD20 antibody therapy. J Immunol 2014;192(3):897-905.
74. Ellis JS, Braley-Mullen H. Regulatory T cells in B cell-deficient andWT mice differ functionally and in expression of cell surfacemarkers. Immunology 2014;144(4):598-610.
75. Zabel KM, Rawitch AB. Thyroglobulin structure-function: The effect of iodination on the structure of human thyroglobulin. Biochem Biophys Res Commun 1984;121(1):310-316.
76. Chen CR, Hamidi S, Braley-Mullen H, et al. Antibodies to thyroid peroxidase arise spontaneously with age in NOD. H-2h4 mice and appear after thyroglobulin antibodies. Endocrinology 2010;151(9):4583-4593.
77. Yu S, Sharp GC, Braley-Mullen H. Dual roles for IFN-gamma, but not for IL-4, in spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J Immunol 2002;169(7):3999-4007.
78. Yu S, Sharp GC, Braley-Mullen H. Thyroid epithelial cell hyperplasia in IFN-gamma deficient NOD. H-2h4mice. Clin Immunol 2006;118(1):92-100.
79. Yu S, Fang Y, Sharav T, et al. CD8+ T cells induce thyroid epithelial cell hyperplasia and fibrosis. J Immunol 2011;186(4):2655-2662.
80. Yu S, Sharp GC, Braley-Mullen H. Thyrocytes responding to IFN-gamma are essential for development of lymphocytic spontaneous autoimmune thyroiditis and inhibition of thyrocyte hyperplasia. J Immunol 2006;176(2):1259-1265.
81. Barin JG, Afanasyeva M, Talor MV, et al. Thyroid-specific expression of IFN-gamma limits experimental autoimmune thyroiditis by suppressing lymphocyte activation in cervical lymph nodes. J Immunol 2003;170(11):5523-5529.
82. Braley-MullenH,ChenK,Wei Y, et al. Role ofTGFbeta in development of spontaneous autoimmune thyroiditis in NOD. H-2h4 mice. J Immunol 2001;167(12):7111-7118.
83. Yu S, Fang Y, SharpGC, et al. Transgenic expression of TGF-beta on thyrocytes inhibits development of spontaneous autoimmune thyroiditis and increases regulatory T cells in thyroids of NOD. H-2h4 mice. J Immunol 2010;184(9):5352-5359.
84. Bottazzo GF, Pujol-Borrell R, Hanafusa T, et al. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983;2(8359):1115-1119.
85. Bonita RE, Rose NR, Rasooly L, et al. Adhesion molecules as susceptibility factors in spontaneous autoimmune thyroiditis in the NOD-H2h4 mouse. ExpMol Pathol 2002;73(3):155-163.
86. Sharma RB, Alegria JD, Talor MV, et al. Iodine and IFN-gamma synergistically enhance intercellular adhesion molecule 1 expression on NOD. H2h4 mouse thyrocytes. J Immunol 2005;174(12):7740-7745.
87. Sharma R, Traore K, Trush MA, et al. Intracellular adhesion molecule-1 up-regulation on thyrocytes by iodine of non-obese diabetic. H2(h4)mice is reactive oxygen species-dependent. Clin Exp Immunol 2008;152(1):13-20.
88. Burek CL, Rose NR. Autoimmune thyroiditis and ROS. Autoimmun Rev 2008;7(7):530-537.
89. Kolypetri P, Carayanniotis G. Apoptosis ofNOD. H2 h4 thyrocytes by low concentrations of iodide is associated with impaired control of oxidative stress. Thyroid 2014;24(7):1170-1178.
90. Schweizer U, Chiu J, Kohrle J. Peroxides and peroxide-degrading enzymes in the thyroid. Antioxid Redox Signal 2008;10(9):1577-1592.
91. Smyth PP. Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors 2003;19(3-4):121-130.
92. Bagchi N, Brown TR, Herdegen DM, et al. Antioxidants delay the onset of thyroiditis in obese strain chickens. Endocrinology 1990;127(4):1590-1595.
93. Bernstein SE. Physiological characteristics. In: Green EL, editor. Biology of the laboratory mouse. 2nd ed. New York, NY: Dover Publications; 2007.
94. Taurog A, Chaikoff IL. On the determination of plasma iodine. J Biol Chem 1946;163:313-322.
95. Maree AF, KombaM, Finegood DT, et al. A quantitative comparison of rates of phagocytosis and digestion of apoptotic cells bymacrophages from normal (BALB/c) and diabetes-prone (NOD) mice. J Appl Physiol (1985) 2008;104(1):157-169.
96. O'Brien BA, Geng X, Orteu CH, et al. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NODmouse. J Autoimmun 2006;26(2):104-115.
97. Vitali C, Mingozzi F, Broggi A, et al. Migratory, and not lymphoid-resident, dendritic cells maintain peripheral self-tolerance and prevent autoimmunity via induction of iTreg cells. Blood 2012;120(6):1237-1245.
98. Idoyaga J, Fiorese C, Zbytnuik L, et al. Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest 2013;123(2):844-854.
99. Scheinecker C,McHugh R, Shevach EM, et al. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J ExpMed 2002;196(8):1079-1090.
100. Ganguly D, Haak S, Sisirak V, et al. The role of dendritic cells in autoimmunity. Nat Rev Immunol 2013;13(8):566-577.